Delivery Order SPE2DB20D2001-SPE2DB25FPMEE
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,684.12, is for the delivery of 4567501343 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.51 firm-fixed-price delivery order is for the supply of 4566802887 LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,783.60, is a delivery order contract for the delivery of 4567197460 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of February 7, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.97, is for the delivery of 4567615863 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $2,328.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567038547 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is a delivery order for the supply of 4567491553 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The award is not associated with a set-aside program and has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,180.65 delivery order contract is for the supply of 4567113101 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S. This is a firm fixed-price delivery order contract with a performance period through March 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,301.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567394902 - LISDEXAMFETAMINE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4567502070 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract has an ultimate completion date of March 10, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPMEEDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,274.55, is a Firm Fixed Price Delivery Order for the supply of 4567533906 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/11/25 |